Related Experiment Video
Updated: Dec 27, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
Ana Rio-Machin1, Tom Vulliamy2, Nele Hug3
1Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. a.rio-machin@qmul.ac.uk.
Abstract:
The inclusion of familial myeloid malignancies as a separate disease entity in the revised WHO classification has renewed efforts to improve the recognition and management of this group of at risk individuals. Here we report a cohort of 86 acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) families with 49 harboring germline variants in 16 previously defined loci (57%). Whole exome sequencing in a further 37 uncharacterized families (43%) allowed us to rationalize 65 new candidate loci, including genes mutated in rare hematological syndromes (ADA, GP6, IL17RA, PRF1 and SEC23B), reported in prior MDS/AML or inherited bone marrow failure series (DNAH9, NAPRT1 and SH2B3) or variants at novel loci (DHX34) that appear specific to inherited forms of myeloid malignancies. Altogether, our series of MDS/AML families offer novel insights into the etiology of myeloid malignancies and provide a framework to prioritize variants for inclusion into routine diagnostics and patient management.
Insights
Researchers identified new genetic causes for inherited myeloid malignancies in 86 families. This study advances the understanding and diagnosis of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Familial myeloid malignancies are increasingly recognized as a distinct entity.
- Improved identification and management of at-risk individuals are crucial.
Purpose of the Study:
- To identify germline variants associated with familial myeloid malignancies.
- To expand the understanding of the genetic basis of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Main Methods:
- Analysis of a cohort of 86 acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) families.
- Whole exome sequencing was performed on 37 uncharacterized families.
Main Results:
- Germline variants were identified in 57% of families within 16 known loci.
- Whole exome sequencing identified 65 new candidate loci, including novel genes and previously reported genes in hematological disorders.
- Variants in genes like ADA, GP6, IL17RA, PRF1, SEC23B, DNAH9, NAPRT1, SH2B3, and DHX34 were found.
Conclusions:
- This study provides significant insights into the etiology of inherited myeloid malignancies.
- The findings offer a framework for prioritizing variants for routine diagnostics and patient management.
More Related Videos
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell